pharmaceutical industry

US pharma faces growing risks from Chinese API dependency. This guide explains why traditional methods fail and outlines a proactive framework for China API export monitoring across regulatory, political, and market signals to protect your supply chain.

Discover why traditional stakeholder matrix mapping is a dangerously outdated tool for navigating the complex world of EU pharmaceutical policy. Learn how its static nature creates blind spots and why a shift to dynamic, AI-powered stakeholder intelligence is essential for success.